Can-Fite Biopharma (CANF) P/E (2020 - 2026)
Can-Fite Biopharma (CANF) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Can-Fite Biopharma (CANF) P/E is -1.20. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Can-Fite Biopharma (CANF)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.20 | -17.00% |
| 2025 | -1.45 | -95.03% |
| 2024 | -29.10 | +67.49% |
| 2023 | -17.37 | -34.93% |
| 2022 | -26.70 | -30.06% |
| 2021 | -38.17 | -16.28% |
| 2020 | -45.59 | N/A |
Comparison Can-Fite Biopharma (CANF) P/E with competitors
Can-Fite Biopharma (CANF) P/E is -1.20.